Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Size: px
Start display at page:

Download "Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile"

Transcription

1 Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

2 Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or 2

3 Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Acadia Pharmaceuticals Inc. (Acadia) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Acadia s lead product is Nuplazid (pimavanserin) is a FDA approved drug for the treatment of Parkinson s disease psychosis. Its other pipeline products include pimavanserin for the treatment of schizophrenia and Alzheimer's disease psychosis; Adrenergic for chronic pain and Muscaninic for glaucoma. The company has partnerships with Allergen for the development of its drug candidates in the therapeutic areas of pain and ophthalmology. It has its operational presence with offices located in Denmark and Switzerland. Acadia is headquartered in San Diego, California, the US. Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3

4 the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH66258D Number of Pages : 29 Report Format : PDF Publisher Information : 4

5 5

6 Table Of Contents for Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deal Details 10Partnerships 10ACADIA Pharma Extends Co-Development Agreement With Allergan 10ACADIA Pharma Extends Drug Discovery Collaboration With Allergan 11Licensing Agreements 12ACADIA Pharma Terminates Its Licensing Agreement With Biovail For Pimavanserin Tartrate 12Equity Offering 14ACADIA Pharma Prices Public Offering of Shares for USD300 Million 14Acadia Pharma Raises USD209.8 Million in Public Offering of Shares 16Acadia Pharma Completes Public Offering Of Shares For US$115 Million 18Acadia Pharma Completes Private Placement Of Shares And Warrants For US$84 Million 20Acadia Pharma Files Registration Statement For Public Offering Of Common Stock For US$20.8 Million 21Acadia Pharma Completes Private Placement Of US$15 Million 23Acadia Pharmaceuticals Inc. - Key Competitors 25Key Employees 26Locations And Subsidiaries 28Head Office 28Other Locations & Subsidiaries 28Appendix 29Methodology 29About GlobalData 29Contact Us 29Disclaimer 29 6

7 List Of Tables in Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Key Facts, Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Acadia Pharmaceuticals Inc., Deals By Therapy Area, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD ACADIA Pharma Extends Co-Development Agreement With Allergan 10 ACADIA Pharma Extends Drug Discovery Collaboration With Allergan 11 ACADIA Pharma Terminates Its Licensing Agreement With Biovail For Pimavanserin Tartrate 12 ACADIA Pharma Prices Public Offering of Shares for USD300 Million 14 Acadia Pharma Raises USD209.8 Million in Public Offering of Shares 16 Acadia Pharma Completes Public Offering Of Shares For US$115 Million 18 Acadia Pharma Completes Private Placement Of Shares And Warrants For US$84 Million 20 Acadia Pharma Files Registration Statement For Public Offering Of Common Stock For US$20.8 Million 21 Acadia Pharma Completes Private Placement Of US$15 Million 23 Acadia Pharmaceuticals Inc., Key Competitors 25 Acadia Pharmaceuticals Inc., Key Employees 26 Acadia Pharmaceuticals Inc., Subsidiaries 28 7

8 List Of Figures, Charts and Diagrams in Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD Acadia Pharmaceuticals Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD

9 How to Buy... Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and

More information

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research

More information

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited

More information

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market

More information

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector

More information

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile BioPortfolio has

More information

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Sector Publishing

More information

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence

More information

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review Sector Publishing Intelligence Limited (SPi) has been marketing business and market

More information

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence Ltd.

More information

Phone: +44 (0) or BioPortfolio Limited

Phone: +44 (0) or   BioPortfolio Limited Global Laser Holographic Display Market by Product (Medical Scanners, Digital Signage, Kiosk, Notebook), by Application (Medical, Commercial, Industrial, Defense, Consumer Electronics), by Geography -

More information

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment

More information

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Devices), and Sutures (Sutures by Type (Absorbable & Non-Absorbable),

More information

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from

More information

Critical Limb Ischemia - Pipeline Review, H1 2017

Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over

More information

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease

More information

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Generics Series: Authorized Generics Analysis Stemming the Generics Tide Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players

More information

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business and market research

More information

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context

More information

Omeros Raises More Than $63 Million in Financing

Omeros Raises More Than $63 Million in Financing Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,

More information

United States Sterilization Equipment Market Outlook to 2021

United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected

More information

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, Transparency Market Research Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 2018 Buy Now Request Sample Published Date: Mar 2013 Single User

More information

Digital Health Funding and M&A

Digital Health Funding and M&A Digital Health Funding and M&A 2018 Third Quarter and Nine Month Report Funding and Merger & Acquisition activity for the Digital Health sector http://www.mercomcapital.com 1 Copyright 2010-2016 Mercom

More information

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your

More information

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved. Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:

More information

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) By Type of Approach-

More information

VentureSource Europe -- 3Q 2014

VentureSource Europe -- 3Q 2014 Europe -- 3Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, and liquidity. The included charts and graphs offer a

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 1Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio SECA conference Zurich, 3 July 2013 Dr. Andreas Wicki, CEO HBM at a Glance SIX-listed investment company

More information

Global Paper Stationery Market Research Report 2016

Global Paper Stationery Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Paper Stationery Market Research Report 2016 Global Paper Stationery Market Research Report 2016 Publication

More information

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,

More information

Purvi B. Maniar Member of the Firm

Purvi B. Maniar Member of the Firm Purvi B. Maniar Member of the Firm New York 250 Park Avenue New York, New York 10177 Tel: 212-351-3757 Fax: 212-878-8600 St. Louis Tel: 314-395-2775 pmaniar@ebglaw.com PURVI B. MANIAR is a Member of the

More information

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd. Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo 2011 Dr. Axel Braun F. Hoffmann La Roche Ltd. Content Roche Company Profile The IP Department Patent Filings Global Strategy Sales Overview IP

More information

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is

More information

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011 Scripps Florida Accelerating Discoveries, Saving Lives Presentation to the Urban Land Institute November 4, 2011 Alex Bruner Associate Vice President, Philanthropy 1921- Founding of the Scripps Metabolic

More information

State of Licensing 2011 Update

State of Licensing 2011 Update State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-

More information

Indoor Positioning and Navigation System Market Research Report- Forecast 2023

Indoor Positioning and Navigation System Market Research Report- Forecast 2023 Report Information More information from: https://www.marketresearchfuture.com/reports/1775 Indoor Positioning and Navigation System Market Research Report- Forecast 2023 Report / Search Code: MRFR/SEM/1243-CRR

More information

Intellectual property governance and strategic value creation:

Intellectual property governance and strategic value creation: Intellectual property governance and strategic value creation: some evidence from European organizations in, pharmaceutical and public research fields Dr. Federica Rossi (rossi.federica@unito.it) Universita

More information

Venture Capital Report

Venture Capital Report Venture Capital Report Europe 3Q 2015 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included

More information

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017 Cherry AB Investing in a broad gaming portfolio CEO Anders Holmgren GP Bullhound 6 December 2017 The game is on Cherry is investing in a broad portfolio of online gaming companies Cherry s strategy is

More information

Global Absolute Pressure Transmitters Market Research Report 2016

Global Absolute Pressure Transmitters Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Absolute Pressure Transmitters Market Research Report 2016 Global Absolute Pressure Transmitters Market Research

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 2 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

Global DAW Software Market Research Report 2016

Global DAW Software Market Research Report 2016 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global DAW Software Market Research Report 2016 Global DAW Software Market Research Report 2016 Publication ID:

More information

China Ophthalmic Hospital Industry Report, May 2013

China Ophthalmic Hospital Industry Report, May 2013 China Ophthalmic Hospital Industry Report, 2012-2015 May 2013 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight

More information

New York Bar admission (or eligibility to obtain admission promptly) is required.

New York Bar admission (or eligibility to obtain admission promptly) is required. Job Opportunities To apply to any of the positions send cover letter referencing job opening with resume and salary requirements to info@bryantrabbino.com Senior Level Corporate Finance Attorney We are

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3. 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.1 Spinal Cord Stimulator 3.2 Deep Brain Stimulator 3.3 Vagus Nerve Stimulator

More information

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number

More information

2013 Global venture capital confidence survey results. How confident are investors?

2013 Global venture capital confidence survey results. How confident are investors? 2013 Global venture capital confidence survey results How confident are investors? August 14, 2013 Contents Survey methodology, demographics and key findings Economic trends Regional and country investing

More information

Chartwell Introduction and AEC Capabilities

Chartwell Introduction and AEC Capabilities Chartwell Introduction and AEC Capabilities Comprehensive Financial Advisory Experience Chartwell provides financial advisory solutions to the middle market; areas of expertise include corporate finance,

More information

CV SCIENCES, INC. (Exact name of registrant as specified in its charter)

CV SCIENCES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.

gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp. gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp.com Summary Personal Diverse, world-class team of top biotech bankers,

More information

François G. Laugier's Representative Experience

François G. Laugier's Representative Experience François G. Laugier's Representative Experience Practice Area: International, Mergers & Acquisitions Key Issues: Acquisitions (For Buyer) Client Type: Foreign Publicly-Traded Naval Technology Company Description:

More information

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant

More information

Monitoring R&D resource flows: Global resources and challenges

Monitoring R&D resource flows: Global resources and challenges WHO informal workshop: Wellcome Trust, London 14 February 2013 Monitoring R&D resource flows: Global resources and challenges Stephen Matlin Institute of Global Health Innovation Imperial College, London

More information

Venture Capital Report

Venture Capital Report Europe 4Q 2014 The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs

More information

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,

More information

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &

More information

ALANCO TECHNOLOGIES INC

ALANCO TECHNOLOGIES INC SECURITIES & EXCHANGE COMMISSION EDGAR FILING ALANCO TECHNOLOGIES INC Form: 8-K Date Filed: 2016-10-04 Corporate Issuer CIK: 98618 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution

More information

Global and China Industrial Robot Industry Report, Sep. 2013

Global and China Industrial Robot Industry Report, Sep. 2013 Global and China Industrial Robot Industry Report, 2013 Sep. 2013 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis,

More information

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950 Military Robotics - Emerging Trends and Future Outlook Reference code: DF4580PR Published: July 2015 Single user price: US$1950 1 Summary Military Robotics - Emerging Trends and Future Outlook is a report

More information

Annual Press Conference Financial year 2017

Annual Press Conference Financial year 2017 Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals

More information

Financing SMEs and Entrepreneurs 2012

Financing SMEs and Entrepreneurs 2012 Financing SMEs and Entrepreneurs 2012 AN OECD SCOREBOARD OECD Table of Contents Acronyms and abbreviations 13 Chapter 1. Financing SMEs and Entrepreneurs: Understanding and Developing an OECD Scoreboard

More information

Global and China Industrial Robot Speed Reducer Industry Report, Jun. 2014

Global and China Industrial Robot Speed Reducer Industry Report, Jun. 2014 Global and China Industrial Robot Speed Reducer Industry Report, 2013-2016 Jun. 2014 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information,

More information

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our

More information

VentureSource U.S. -- 4Q 2013

VentureSource U.S. -- 4Q 2013 U.S. -- 4Q 2013 The following report presents DJX VentureSource s quarterly findings for U.S. venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive

More information

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis

More information

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded

More information

Kandace P. Watson Partner

Kandace P. Watson Partner Kandace P. Watson Partner 12275 El Camino Real Suite 200 San Diego, CA 92130 T: 858.720.8930 F: 858.523.6770 kwatson@sheppardmullin.com Practices Healthcare Corporate Mergers and Acquisitions Technology

More information

Global Sequins Apparels Market Research Report 2016

Global Sequins Apparels Market Research Report 2016 Report Information More information from: https://www.wiseguyreports.com/reports/812531-global-sequins-apparels-market-research-report-2016 Global Sequins Apparels Market Research Report 2016 Report /

More information

World Offshore Wind Market Forecast Prospects, Technologies, World Markets

World Offshore Wind Market Forecast Prospects, Technologies, World Markets 2016 World Offshore Wind Market Forecast 2016-2025 Prospects, Technologies, World Markets Contents Table of Contents 1 Summary and Conclusions...7 Summary... 8 Conclusions... 9 2 Drivers and Indicators...

More information

GLOBAL PRIVATE EQUITY Report Charts

GLOBAL PRIVATE EQUITY Report Charts GLOBAL PRIVATE EQUITY 2003 Report Charts THE WORLD VIEW Investment & Fund Raising Trends THE WORLD VIEW 2002 Main Headlines At least $102 billion of private equity and venture capital was invested globally

More information

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association Transaction Services Profile BridgeLink M&A und Corporate Finance BridgeLink is an international service company providing comprehensive solutions in M&A and Corporate Finance. We are located in Basel

More information

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment Presenter: Randall Sunberg Morgan Lewis May 16, 2008 In cooper Biography Randall Sunberg partner Morgan Lewis, Princeton Phone: 609.919.6606 Randall B. Sunberg is a partner in Morgan Lewis's Business and

More information

Venture Capital Report

Venture Capital Report Venture Capital Report China 1 Q 2018 The following report presents Dow Jones VentureSource s quarterly findings for Chinese venture capital fundraising, investment, valuation, and liquidity. The included

More information

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden

Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden 2010 Bilcare Technologies. Privileged presentation, slide 1 Singular ID The Story of Commercialising a Materials Technology in Singapore Adrian Burden Co-founding Director of Singular ID President Europe

More information

FOREST LABORATORIES, INC. AND DAIICHI SANKYO, INC. ANNOUNCE THE TERMINATION OF THE AZOR CO-PROMOTION AGREEMENT

FOREST LABORATORIES, INC. AND DAIICHI SANKYO, INC. ANNOUNCE THE TERMINATION OF THE AZOR CO-PROMOTION AGREEMENT For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and Representative Director (Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)

More information

Mara H. Rogers, Partner Norton Rose Fulbright

Mara H. Rogers, Partner Norton Rose Fulbright Mara H. Rogers Partner Norton Rose Fulbright US LLP New York T:+1 212 318 3206 F:+1 212 318 3400 mara.rogers@nortonrosefulbright.com vcard (+Outlook) Related services Corporate, M&A and securities Mergers

More information

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT CRITICAL THINKING AT THE CRITICAL TIME ABOUT US The Global Risk and Investigations Practice (GRIP) of FTI Consulting is the leading provider of

More information

Intellectual Property Policy. DNDi POLICIES

Intellectual Property Policy. DNDi POLICIES Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments

More information

Raising Capital. Get the Money You Need to Grow Your Business. Third Edition. Andrew J. Sherman

Raising Capital. Get the Money You Need to Grow Your Business. Third Edition. Andrew J. Sherman \ Raising Capital Get the Money You Need to Grow Your Business Third Edition Andrew J. Sherman AMACOM American Management Association New York Atlanta Brussels Chicago Mexico City San Francisco Shanghai

More information